Benzinga's Top #PreMarket Losers
Gilead Sciences Inc. (NASDAQ: GILD) shares dropped 9.73% to $97.90 in pre-market trading. Gilead Sciences and Ono Pharma reported that the companies have entered into an exclusive license agreement for the development and commercialization of ONO-4059.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares fell 3.14% to $115.17 in pre-market trading after gaining 0.99% on Friday.
Energy XXI Ltd. (NASDAQ: EXXI) shares declined 2.92% to $3.33 in pre-market trading after jumping 11.00% on Friday.
Randgold Resources Limited (NASDAQ: GOLD) fell 1.22% to $66.70 in pre-market trading after dropping 1.32% on Friday.
Biogen Idec Inc. (NASDAQ: BIIB) shares dropped 1.57% to $354.99 after gaining 1.97% on Friday.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.